Pharmacology & Cancer Biology | Duke University Medical Center

Seminar Series - The Pharmacology & Cancer Biology weekly Signal Transduction Colloquium Seminar Series is held on Wednesdays at 12:00 PM in 103 Bryan Research Building.

Date	Speaker	Institution	Title
9/12/2007	Dean Felsher, M.D., Ph.D.	Stanford University	“Tumor intrinsic and host-dependent mechanisms of oncogene addiction”
9/19/2007	Len Neckers	National Cancer Institute	“Regulation of HSP90 chaperone dynamics by the post-translational modification acetylation”
9/26/2007	Melanie Cobb, Ph.D.	UT-Southwestern Medical Center	“WNKs, roles in ion transport and vesicular trafficking"
10/3/2007	Alan D'Andrea, M.D.	Dana-Farber Cancer Institute	“The Fanconi Anemia Pathway and the DNA Damage Response"
10/10/2007	Karl Deisseroth, M.D., Ph.D.	Stanford University	“Multimodel fast optical interrogation of neural circuitry: Development and applications”
10/17/2007	J. Paul Taylor, M.D., Ph.D.	University of Pennsylvania	“HDAC6 at the intersection of autophagy, the ubiquitin-proteasome system, and neurodegeneration”
10/24/2007	Karlene Cimprich, Ph.D.	Stanford University	“Mechanisms for sensing and responding to DNA damage”
10/31/2007	Gretchen Darlington, Ph.D.	Baylor College of Medicine	“Altered xenobiotic metabolism in long-lived mice”
11/7/2007	Marian Carlson, Ph.D.	Columbia University	“Regulation of SNF1 / AMPK pathways”
11/14/2007	Nicholas Dyson, M.D.	Massachusetts General Hospital/Harvard University	“Roles of RB / RBF proteins in cell cycle control”
11/21/2007	No Seminar - Thanksgiving Holiday
11/28/2007	Tak Mak, Ph.D.	University of Toronto	“Did the oncogene revolution setback clinical oncology?”
12/5/2007	David Morgan, Ph.D.	University of California, San Francisco	“Finishing Mitosis”
12/12/2007	Geoffrey Pitt, M.D., Ph.D.	Duke University Medical Center	“Calcium regulation of excitable membranes”
1/16/2008	Laurie Goodyear, Ph.D.	Joslin Diabetes Center-Harvard	“Signaling mechanisms regulating glucose transport in skeletal muscle: AMPK, CaMKs, and Rab GTPases”
1/23/2008	Gerard Evan, Ph.D.	University of California-San Francisco	How tumor suppressors suppress and oncogenes “ONC”
1/30/2008	Peter Tontonoz, M.D., Ph.D.	University of California-Los Angeles	“LXR signaling pathways in lipid metabolism and inflammation”
2/6/2008	David Mangelsdorf, Ph.D.	UT-Southwestern Medical Center	“Nuclear receptor regulation of metabolism”
2/13/2008	Tyler Jacks, Ph.D.	MIT	“Modeling Cancer in the Mouse”
2/20/2008	Paul Rosenberg, M.D.	Duke University Medical Center	“Novel calcium entry pathways in striated muscle”
2/27/2008	Warren Pear, M.D., Ph.D.	University of Pennsylvania	“The myriad functions of Notch in the immune system”
3/5/2008	Joanna Wysocka, Ph.D.	Stanford University	“Studying histone methylation: a PHD is not enough”
3/12/2008	Chris Counter, Ph.D.	Duke University	“Ras oncogene addiction”
3/19/2008	Zena Werb, Ph.D.	University of California, San Francisco	“Transcriptional regulation of mammary development and breast cancer progression”
3/26/2008	Shin-Ichiro Imai, M.D, Ph.D.	Washington University	“The NAD World: a new regulatory system for metabolism and aging – systemic NAD biosynthesis, Sirt1, and their importance”
4/2/2008	Cheryl Walker, Ph.D.	M.D. Anderson Cancer Center	“Crosstalk between the ATM damage response and the mToR signaling pathways”
4/9/2008	Piotr Sicinski, M.D., Ph.D.	Dana-Farber Cancer Institute	“Cell cycle machinery in mouse development and in cancer”
4/16/2008	Arturo Alvarez-Buylla, Ph.D.	University of California, San Francisco	“Postnatal neural stem cells and their niche”

Top of page